Companies by HQ LocationTech Companies and Startups Headquartered in Cambridge
279 companies in this collection.
List of companies headquartered in Cambridge
Select...
Loading...
Page 1 of NaN
Displaying companies
A machine learning and artificial intelligence platform company. | Cambridge | MA | 2 - 10 | 2024 | $3,150,000 |
Sora Fuel makes jet fuel from just air, water, and renewable energy. Sora Fuel combine carbon capture and utilization into a single process, dramatically reducing the amount of energy required to produce SAF, enabling a truly affordable, carbon-negative dr | Cambridge | MA | 2 - 10 | 2024 | $6,000,000 |
Koya AI helps data aggregators such as marketplaces and procurement platforms to manage catalog data seamlessly. Instead of spending days manually chasing down, standardizing, and enriching product data, marketplaces can rely on Koya’s data-as-a-service of | Cambridge | MA | 1 - 10 | 2023 | $3,000,000 |
VULCAN ELEMENTS is changing the way to electrify aerospace, defense, and auto with decarbonization. | Cambridge | MA | 2 - 10 | 2023 | $5,201,998 |
Liquid AI is a developer of AI applications that help improve human experience. It focuses on researching and developing tools that use artificial intelligence to improve creative workflows and help clients manage their workflow efficiently. | Cambridge | MA | 10 - 50 | 2023 | $43,200,000 |
Synthpop is a company that develops AI-driven solutions to streamline healthcare workflows and improve patient care. The company's platform leverages advanced technologies to automate data entry, insurance verification, and other administrative tasks, free | Cambridge | MA | 10 - 50 | 2023 | $8,200,000 |
Marveri is a legal AI startup out of MIT & Harvard. We’re focused on revolutionizing the legal industry and backed by top-tier investors. We are currently in stealth. | Cambridge | MA | 2 - 10 | 2023 | $3,000,000 |
Sesame Sustainability is a SAAS company that offers industrial decarbonization platform for modeling, optimization, and analysis. | Cambridge | MA | 1 - 10 | 2023 | $2,400,000 |
Symbionics is a brain-computer interface company that focuses on the development of interface devices to integrate humans and machines. | Cambridge | MA | 5 - 10 | 2023 | 4103967 CNY |
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites | Cambridge | MA | 50 - 100 | 2023 | $30,877,444 |
Developer of the world's first cloud-native operating system, DBOS, and the DBOS Cloud transactional serverless computing platform. A simpler, more secure way to build fault-tolerant cloud applications. Based on 3 years of joint MIT-Stanford research, led | Cambridge | MA | 5 - 20 | 2023 | $8,500,000 |
Osmo gives computers a sense of smell that improves the health & wellbeing of human life. | Cambridge | MA | 20 - 50 | 2023 | $63,500,000 |
MacroCycle is developing a technology to curb the usage of fossil fuel derived plastic through a circular, sustainable and zero-carbon plastic upcycling process. The company's proprietary process based on the synthesis of cyclic macromolecules enables us t | Cambridge | MA | 1 - 10 | 2023 | $1,075,000 |
Pascal is an early stage Boston-based clean technology company, commercializing solid refrigerant heat pumps and air conditioners. The HVAC sector currently accounts for 30% of total global energy usage while also directly emitting 1.5 GTon CO2 eq. of gree | Cambridge | MA | 10 - 50 | 2023 | $8,000,000 |
DEM Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘Don’t eat me’ (DEM) and ‘Eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund and is | Cambridge | MA | 20 - 50 | 2022 | $70,000,000 |
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible. | Cambridge | MA | 20 - 100 | 2022 | $270,000,000 |
FORAY bioscience is a biotechnology company that uses biomanufacturing techniques to produce wood products. | Cambridge | MA | 2 - 10 | 2022 | $3,413,246 |
Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies us | Cambridge | MA | 5 - 20 | 2022 | $2,425,000 |
Pramana, Inc is a new health technology company from nference that enables digital transformation for next-generation pathology at medical centers and pathology labs. Pramana offers a first-in-class Digital Pathology as a Service (DPaaS) solution by provid | Cambridge | MA | 50 - 200 | 2022 | $30,000,000 |
Istari makes digital engineering ecosystems a reality where all technologies are created digitally, free from real-world costs, schedules, and environmental impacts. | Cambridge | MA | 20 - 50 | 2022 | $13,000,000 |
Founded by Flagship Pioneering, Empress re-imagines the process of small molecule drug discovery. Our bioplatform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to focus on endogenous sources of inherently d | Cambridge | MA | 20 - 50 | 2022 | $50,000,000 |
Sleepagotchi rewards users with a digital collectible for sticking to a consistent sleep schedule that they set for themselves in order to promote healthy sleeping habits. | Cambridge | MA | 10 - 50 | 2022 | $3,500,000 |
Via Scientific to help scientists and bioinformaticians generate novel science that improves the world. It was founded in 2022. | Cambridge | MA | 10 - 50 | 2022 | $5,000,000 |
We develop scalable quantum computers to tackle the world’s hardest computational challenges. Join us: https://jobs.polymer.co/atlantic-quantum. | Cambridge | MA | 5 - 20 | 2022 | $11,800,000 |
Montai is harnessing nature's power through digital technology to treat and prevent chronic disease, hence improving health outcomes for as many people as possible. To address this crucial global concern, the business is pioneering cutting-edge technology | Cambridge | MA | 20 - 50 | 2022 | $50,000,000 |
Wild Microbes is a next-generation microbial platform that makes everything from plastics to proteins. They develop new microbial strains, making scaling sustainable products faster and cheaper than ever. | Cambridge | MA | 5 - 20 | 2022 | $3,300,000 |
Cartwheel offers mental health support to students in order to help schools regain balance in the midst of the student mental health crisis. It works hand in hand to empower school staff, reduce family stress, and improve all students' mental health outcom | Cambridge | MA | 5 - 20 | 2022 | $20,000,000 |
Datalign Advisory is a financial advisory firm that connects clients with a network of financial advisers. | Cambridge | MA | 10 - 50 | 2022 | $4,000,000 |
Entro is a revolutionary cyber security platform that provides protection for secrets and programmatic access to cloud services and data. They assist in accelerating business growth and success by building a safe cloud environment. | Cambridge | MA | 20 - 50 | 2022 | $24,000,000 |
Tailbox is an MIT-backed startup bringing locations to life through generative AI powered stories. Our location-based social platform for explorers focuses on uncovering hidden gems and unique narratives in every city through immersive storytelling and per | Cambridge | MA | 5 - 10 | 2022 | $1,850,000 |
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the ability to create therapeutics. | Cambridge | MA | 20 - 50 | 2022 | $75,000,000 |
Digital twins are revolutionizing industries from aerospace to agriculture. Istari makes them simple and more secure, unlocking models and simulations for better products - better everything. A faster, cheaper, greener digital future awaits.
With Istari, | Cambridge | MA | 20 - 50 | 2022 | $13,000,000 |
NuMind is a manufacturing company currently based in Cambridge, Massachusetts, United States. It has been founded in 2022 by Etienne Bernard and Samuel Bernard. | Cambridge | MA | 5 - 10 | 2022 | $3,500,000 |
Diagonal Therapeutics is a biotechnology startup that is pioneering a novel technique to finding and producing agonist antibodies. Diagonal Therapeutics platform combines novel computational and experimental methodologies to solve the traditional obstacles | Cambridge | MA | 10 - 50 | 2022 | $128,000,000 |
Mantel is developing the first molten-salt based carbon capture technology. Our molten borates are designed to operate at the high temperatures found inside boilers, kilns, and furnaces – enabling highly efficient carbon capture that has not been possible | Cambridge | MA | 5 - 20 | 2022 | $2,000,000 |
Nvelop Therapeutics is a biotechnology company that provides gene editing technology services for unmet major disease needs. | Cambridge | MA | 10 - 50 | 2022 | $100,000,000 |
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs). It is designed to address complex diseases by targeting rare combinations of proteins that work together. | Cambridge | MA | 5 - 10 | 2022 | $20,000,000 |
Suno is a music start-up that enables anyone to make the songs they want. The company aims to help people rediscover the joy of play and exploration. | Cambridge | MA | 10 - 50 | 2022 | $125,000,000 |
StataDX is building the world's first point-of-care diagnostics platform for Neurology. | Cambridge | MA | 5 - 10 | 2022 | $3,200,000 |
Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries | Cambridge | MA | 2 - 10 | 2022 | $6,999,999 |
Wecover Platforms creates AI-powered PaaS for Property and Casualty Insurance Industry | Cambridge | MA | 5 - 10 | 2022 | $6,600,000 |
Foundation Alloy leverage advanced materials technology to design novel alloys optimized for additive manufacturing. | Cambridge | MA | 5 - 10 | 2022 | $10,500,000 |
With Stack AI, any organization can build and deploy custom AI Assistants in minutes. Our no-code interface allows teams to leverage AI for searching through knowledge bases, automating workflows, and building chatbots. Hundreds of companies use Stack AI | Cambridge | MA | 5 - 20 | 2022 | $3,000,000 |
Crossbow Therapeutics is a seed-stage, stealth-mode oncology startup company. The company develops antibody engineering for intracellular cancer targets. | Cambridge | MA | 10 - 50 | 2021 | $80,000,000 |
Apollon offers more simple diagnostic techniques. It can detect inflammatory substances in a single blood sample and measure blood sugar without collecting blood. All of this is possible because light can unlock the signal of chemical bonds in molecules wi | Cambridge | MA | 10 - 50 | 2021 | $2,800,000 |
Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer | Cambridge | MA | 5 - 10 | 2021 | $130,000,000 |
Themis AI, a spinoff from CSAIL MIT, was founded by MIT alumni and professors to empower the world to create, advance, and deploy trustworthy AI. Themis' technology enables trustworthy AI in high risk scenarios, rare events and anywhere imbalances and bias | Cambridge | MA | 10 - 50 | 2021 | $2,000,000 |
Thousands of collectors use evaluate.market to analyze NFTs. We are a remote, venture-backed company that is changing how people buy, sell, and analyze digital collectibles. Connect with us on Twitter and join our Discord to learn more. | Cambridge | MA | 5 - 20 | 2021 | $7,291,992 |
AvenCell is a modular antibody complex technology. | Cambridge | MA | 20 - 100 | 2021 | $112,000,000 |
ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's innovative scientists and inv | Cambridge | MA | 200 - 500 | 2021 | $1,246,000,000 |
Robigo is a biopesticide engineering the plant microbiome to reduce disease in crops. | Cambridge | MA | 5 - 20 | 2021 | $8,000,000 |
Flare Therapeutics is a biotechnology company opening up a new therapeutic space with a novel approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of its scientific founders, | Cambridge | MA | 20 - 100 | 2021 | $205,000,000 |
OpenEvidence Information overload is a common problem in many high-value domains. It's a huge challenge in medicine. With such a rate of change, it is practically impossible for the world's physicians, medical scientists, and healthcare professionals to k | Cambridge | MA | 10 - 50 | 2021 | $32,000,000 |
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA. Their First in Class approach for protein editing advances beyond genome editing to direct modification of the proteome. | Cambridge | MA | 20 - 50 | 2021 | $40,000,000 |
Anumana is an AI-driven company that develops ECG algorithms enabling early disease diagnosis and intervention. | Cambridge | MA | 50 - 200 | 2021 | $117,700,000 |
Tutor Intelligence is on a mission to bring robots to places they've never been before. We have made it cheap and easy for businesses of all sizes to hire robots as drop-in solutions for picking, placing, pal/depal, material handling, sorting, kitting, ins | Cambridge | MA | 5 - 20 | 2021 | $4,162,206 |
Dianthus is the world’s only AI-first E-commerce company – built from the ground up to help small to medium E-commerce brands. | Cambridge | MA | 5 - 20 | 2021 | $11,500,000 |
Metaphore Biotechnologies use biomimicry and machine learning to unveil the revolutionary medicinal potential of functional molecular mimics. The MIMiCTM platform, developed by the business, is a computationally driven bio platform for developing novel the | Cambridge | MA | 20 - 50 | 2021 | $50,000,000 |
Mirai Bio has developed an open platform powered by AI to address the main drawbacks and manufacturing to develop the future of genetic medicine. | Cambridge | MA | 10 - 50 | 2021 | $50,000,000 |
Skylark Bio is a biotechnology company that develops gene therapies to treat hearing losses. The company was founded in 2021 and is based in Cambridge, Massachusetts, United States. | Cambridge | MA | 5 - 10 | 2021 | $40,889,316 |
Fizz is building a debit card that helps college students in the U.S. started building out their credit without having to learn lessons about overzealous credit use the hard way. | Cambridge | MA | 20 - 50 | 2021 | $14,525,000 |
Gesund.ai orchestrates the AI as-a-Medical Device lifecycle, providing privacy-centered access to diverse yet standardized medical data sources, and a unique analytical toolbox that fosters clinical validation, regulatory clearance and effective marketing. | Cambridge | MA | 20 - 50 | 2021 | $3,000,000 |
Ketryx is an information technology company that features software development tools built for developers, by developers. | Cambridge | MA | 20 - 100 | 2021 | $18,049,994 |
Beta Finance is a permissionless money market protocol for lending, borrowing, and short-selling crypto assets. It aims to offset crypto volatility and bring market stability. Its one-click solution enables traders without technical know-how to manage and | Cambridge | MA | 10 - 50 | 2021 | $5,750,000 |
Seeded by Atlas Venture and The Column Group and in stealth-mode, Judo Bio is pioneering development of a new class of precision therapeutics targeting specific cell populations, a platform that will ultimately have the potential to address significant unm | Cambridge | MA | 5 - 10 | 2021 | $100,000,000 |
Axoft’s bioinspired, scalable implant promotes long-term communication with the nervous system - transforming clinical outcomes, individual health, and the human experience. | Cambridge | MA | 20 - 50 | 2021 | $8,000,000 |
Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting m | Cambridge | MA | 20 - 50 | 2021 | $75,000,000 |
Yard Stick measures soil carbon. Scientists and farmers alike know that climate-friendly agricultural practices have the potential to remove atmospheric CO2 at gigaton/year scale. When these practices are adopted, more carbon is stored in soils, improving | Cambridge | MA | 10 - 50 | 2021 | $36,020,856 |
ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease. RNA delivery systems with a comprehensive RNA platform that allows for an all-RNA system for coding, editing, and gene insertion to produce new medications. | Cambridge | MA | 100 - 500 | 2021 | $300,000,000 |
Prologue Medicines creates transformative medicines by systematically discovering and evaluating viral proteins and their unique features. | Cambridge | MA | 1 - 10 | 2021 | $50,000,000 |
Kano Therapeutics enables safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials. | Cambridge | MA | 5 - 20 | 2021 | $7,100,000 |
Atavistik Bio is a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control | Cambridge | MA | 20 - 50 | 2021 | $100,000,000 |
Sunbird Bio is a leader in protein-based diagnostic tests, becoming the first company to overcome the challenge of accurately detecting and differentiating the specific proteins that aggregate, and therefore signal the presence of Alzheimer’s disease, with | Cambridge | MA | 5 - 20 | 2021 | $14,000,000 |
Fourth Power is an energy storage startup that uses thermal batteries. Through utility-scale thermal storage, the technique transforms renewable energy into an on-demand energy source. | Cambridge | MA | 2 - 10 | 2021 | $19,000,000 |
FYTO is a technology company that develops systems that grow high quality crops using much less resources. | Cambridge | MA | 5 - 10 | 2021 | $32,959,998 |
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases. | Cambridge | MA | 50 - 200 | 2021 | $134,000,000 |
SanaHeal provider of a bioadhesive tape designed to bind to tissues or organs | Cambridge | MA | 5 - 10 | 2021 | $2,315,000 |
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by indust | Cambridge | MA | 500 - 1,000 | 2021 | $550,000,000 |
Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases. | Cambridge | MA | 20 - 100 | 2021 | $95,000,000 |
We are reinventing a future Internet. Private. Personal. Relevant. Powered by extraordinary technology. No cookies harmed in the process. | Cambridge | MA | 2 - 10 | 2021 | $1,400,000 |
Osmoses engages in decarbonizing gas separations to eliminate one gigaton of carbon emissions per year. | Cambridge | MA | 10 - 20 | 2021 | $14,100,000 |
Stack is a B2B SaaS computer vision information system company that aims to rethink the way warehouses are managed across the United States. | Cambridge | MA | 5 - 20 | 2021 | $500,000 |
Heyday Health offers primary care for adults providing in-home and video visits, clinical team, and continuous accessibility. | Cambridge | MA | 10 - 50 | 2021 | $12,500,000 |
Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses. The company's proprietary Advanced Covalent Exploration (ACE) platfo | Cambridge | MA | 20 - 50 | 2021 | $100,000,000 |
K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies. | Cambridge | MA | 5 - 20 | 2021 | $100,000,000 |
Fluent Metal is developing production-grade liquid metal printing technology for more functional, sustainable, and economical metal parts. Our innovative approach allows for high scalability and process tunability, making high-quality metal AM more attaina | Cambridge | MA | 10 - 50 | 2020 | $5,500,000 |
SalioGen Therapeutics advances in curative genetic therapies using its Exact DNA Integration Technology (EDIT) platform, a mammal-derived genome engineering technology. It is focused on providing durable, safe, and affordable non-viral gene therapies to mo | Cambridge | MA | 50 - 200 | 2020 | $135,000,000 |
Kiwi biosciences is a biotech company that develops enzymes to make food for patients who suffer from Irritable Bowel Syndrome (IBS). The company was founded in 2020 and is based in Somerville, Massachusetts, United States. | Cambridge | MA | 5 - 10 | 2020 | $1,500,000 |
Parallel Bio created a human 'immune system in a dish' to discover drugs and immunotherapies more likely to work in patients. | Cambridge | MA | 5 - 20 | 2020 | $4,625,000 |
SiTration improves ultra-durable filtration membranes intended for efficient separations in the harshest environments.Brendan Smith established the company in Cambridge, Massachusetts in 2020. | Cambridge | MA | 5 - 20 | 2020 | $14,405,996 |
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins. | Cambridge | MA | 5 - 20 | 2020 | $37,381,000 |
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. | Cambridge | MA | 50 - 200 | 2020 | $107,000,000 |
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system to identify and specifically destroy hard-to-treat tumors bearing common driver mutations, regardless of tumor type. | Cambridge | MA | 10 - 50 | 2020 | $150,000,000 |
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease. Founded by world-renowned experts in renal disease, Walden is applying its unique, systems-based approach to address the intersection between the patholo | Cambridge | MA | 20 - 50 | 2020 | $51,000,000 |
Common Sense Machines is building artificial intelligence that learns to translate the world into a 3D simulation. Our platform, Real-to-Sim-to-Real, leverages the flexibility of human-like learning and the speed and precision of machines to enable one-sho | Cambridge | MA | 50 - 100 | 2020 | $10,079,994 |
Hosta Labs automates the analysis of images and videos of interior structures for property insurance carriers to provide a full in-depth view of accurate replacement values and risks in the underwriting process and on raw material quantities and mitigation | Cambridge | MA | 10 - 50 | 2020 | $14,742,466 |
Woho enables a new way to build, assembling a team, network, and system to construct from low to high-rise structures with unprecedented quality, precision, and efficiency. The company was founded in 2020 and based in Cambridge, Massachusetts. | Cambridge | MA | 10 - 20 | 2020 | $4,500,000 |
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems | Cambridge | MA | 50 - 100 | 2020 | $122,500,000 |
Neutreeno is a deep tech spinout from the University of Cambridge that engineers an intelligent decarbonization system. | Cambridge | MA | 2 - 10 | 2020 | $5,000,000 |
Faze Medicines is a biotechnology company harnessing the groundbreaking new science of biomolecular condensates to create medical breakthroughs. | Cambridge | MA | 20 - 50 | 2020 | $81,000,000 |
Loading...
Everything You Need, One Platform.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Stay Ahead of the Curve
Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.